NeuRA - Neuroscience Research Australia - Within NeuRA's Spinal Cord Injury Research Centre, Professor Simon Gandevia is leading a landmark international clinical trial aimed at helping people with spinal cord injury to
![Spinal cord injury clinical trials translational process, review of past and proposed acute trials with reference to recommended trial guidelines - ScienceDirect Spinal cord injury clinical trials translational process, review of past and proposed acute trials with reference to recommended trial guidelines - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-B9780444521378000243-f24-01-9780444521378.jpg)
Spinal cord injury clinical trials translational process, review of past and proposed acute trials with reference to recommended trial guidelines - ScienceDirect
![Frontiers | Fighting for recovery on multiple fronts: The past, present, and future of clinical trials for spinal cord injury Frontiers | Fighting for recovery on multiple fronts: The past, present, and future of clinical trials for spinal cord injury](https://www.frontiersin.org/files/Articles/977679/fncel-16-977679-HTML-r1/image_m/fncel-16-977679-g001.jpg)
Frontiers | Fighting for recovery on multiple fronts: The past, present, and future of clinical trials for spinal cord injury
![Frontiers | Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis Frontiers | Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis](https://www.frontiersin.org/files/Articles/695900/fcell-09-695900-HTML-r1/image_m/fcell-09-695900-g001.jpg)
Frontiers | Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
![A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury - ScienceDirect A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1934590918302327-fx1.jpg)
A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury - ScienceDirect
![Spinal Cord Injury Research Program - The Spinal Cord Injury Research Program - Mayo Clinic Research Spinal Cord Injury Research Program - The Spinal Cord Injury Research Program - Mayo Clinic Research](https://www.mayo.edu/-/media/kcms/gbs/research/images/2018/07/31/16/34/spinal-cord-injury-research-program-8col-mss-3610732-0112.jpg)
Spinal Cord Injury Research Program - The Spinal Cord Injury Research Program - Mayo Clinic Research
![Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial - The Lancet Neurology Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial - The Lancet Neurology](https://www.thelancet.com/cms/asset/f76bd13c-cebb-48b3-a01e-e44b9508288d/gr1.jpg)
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial - The Lancet Neurology
![Mapping the Long Rocky Road to Effective Spinal Cord Injury Therapy: A Meta-Review of Pre-Clinical and Clinical Research | Journal of Neurotrauma Mapping the Long Rocky Road to Effective Spinal Cord Injury Therapy: A Meta-Review of Pre-Clinical and Clinical Research | Journal of Neurotrauma](https://www.liebertpub.com/cms/10.1089/neu.2021.0298/asset/images/medium/neu.2021.0298_figure7.jpg)
Mapping the Long Rocky Road to Effective Spinal Cord Injury Therapy: A Meta-Review of Pre-Clinical and Clinical Research | Journal of Neurotrauma
![Heterogeneity among traumatic spinal cord injuries at the thoracolumbar junction: helping select patients for clinical trials | Spinal Cord Heterogeneity among traumatic spinal cord injuries at the thoracolumbar junction: helping select patients for clinical trials | Spinal Cord](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41393-019-0317-x/MediaObjects/41393_2019_317_Fig1_HTML.png)
Heterogeneity among traumatic spinal cord injuries at the thoracolumbar junction: helping select patients for clinical trials | Spinal Cord
![Cells | Free Full-Text | Clinical Trials Using Mesenchymal Stem Cells for Spinal Cord Injury: Challenges in Generating Evidence Cells | Free Full-Text | Clinical Trials Using Mesenchymal Stem Cells for Spinal Cord Injury: Challenges in Generating Evidence](https://www.mdpi.com/cells/cells-11-01019/article_deploy/html/images/cells-11-01019-g001.png)
Cells | Free Full-Text | Clinical Trials Using Mesenchymal Stem Cells for Spinal Cord Injury: Challenges in Generating Evidence
![Ontario leads race to develop stem cell therapy for spinal cord injuries - Ontario Institute for Regenerative Medicine Ontario leads race to develop stem cell therapy for spinal cord injuries - Ontario Institute for Regenerative Medicine](https://oirm.ca/wp-content/uploads/2015/04/oirm-infographic-clinicaltrials11x17-7.jpg)
Ontario leads race to develop stem cell therapy for spinal cord injuries - Ontario Institute for Regenerative Medicine
![Neuroplast enrols first patient in Phase II clinical trial of Neuro-Cells treatment for traumatic spinal cord injury - Spinal News International Neuroplast enrols first patient in Phase II clinical trial of Neuro-Cells treatment for traumatic spinal cord injury - Spinal News International](https://spinalnewsinternational.com/wp-content/uploads/sites/11/2021/11/Neuroplast-logo-766x512-1-300x201.jpg)